PAVmed Inc. (PAVM)

PAVmed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-66.27	-89.26	-50.63	-34.56	-16.73
Depreciation & Amortization	3.24	2.55	0.23	0.02	0.01
Share-Based Compensation	11.14	19.53	15.01	2.04	1.57
Other Operating Activities	-2.24	-4.09	-5.48	10.3	1.52
Operating Cash Flow	-52.04	-70.99	-40.59	-21.91	-13.36
Capital Expenditures	0.76	-1.54	-1.47	-0.06	-0.03
Acquisitions	0	-3.2	-2.25	0	0
Investing Cash Flow	0.76	-4.74	-3.72	-0.06	-0.03
Share Issuance / Repurchase	1.79	0.77	49.79	16.39	5.48
Debt Issued / Paid	9.92	35.23	-14.97	16.7	5.94
Other Financing Activities	19.46	2.22	69.49	-0.09	-0.03
Financing Cash Flow	31.17	38.21	104.31	33.01	11.38
Net Cash Flow	-20.11	-37.51	60	11.04	-2
Free Cash Flow	-51.28	-72.53	-42.06	-21.97	-13.38
Free Cash Flow Margin	-2091.27%	-19237.40%	-8412.00%	-	-
Free Cash Flow Per Share	-7.09	-12.21	-8.14	-6.95	-6.65

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).